Lanean...
Can kinomics and proteomics bridge the gap between pediatric cancers and newly designed kinase inhibitors?
The introduction of kinase inhibitors in cancer medicine has transformed chronic myeloid leukemia from a fatal disease into a leukemia subtype with a favorable prognosis by interfering with the constitutively active kinase BCR-ABL. This success story has resulted in the development of multiple kinas...
Gorde:
| Argitaratua izan da: | Cell Mol Life Sci |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Basel
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565869/ https://ncbi.nlm.nih.gov/pubmed/26321002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00018-015-2019-7 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|